Xylem Inc.
In the published model solve dated 2026-Q2, anchored at $111.31, Xylem Inc. (XYL) is priced for +15.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed June 28, 2026 from SEC EDGAR filings.
• Xylem sells the pumps, treatment systems, smart meters, and services that move and clean water, and the demand sits on a long secular tailwind: scarcity, aging infrastructure, and regulation, with the company reaching municipal customers through channel partners and offering ⟦"filtration and separation, disinfection, and wastewater solutions"⟧ across its segments. • The defining risk is the price, not the business: at roughly 26 times operating income the market embeds about 24.9% annual opera
Is XYL overvalued? See what's priced in →
1,076 institutional managers reported holding XYL in 13F filings for the quarter ended 2026-03-31. Together they hold about 89% of the company; the top 10 hold 43%. 98 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 8.2M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (4.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
XYL's share count grew 34.8% over the past five years even with $698.00M spent on repurchases. It pays a dividend, and has paid one every year in our records (15 and counting), raised 14 years straight; the current rate is $1.60 a share annually. Cash returned over the past three years: $1.01B in dividends and $637.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at XYL over the trailing three years: 2024: 1 buy totaling $1k. 19 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
XYL's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-05 | -3.1% | -13.9% |
| 2023-11-01 | +5.8% | +18.1% |
| 2024-02-29 | +8.1% | +7.0% |
| 2024-05-03 | +4.8% | -2.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
XYL's latest 8-K filings: 2026-08-18 (items 5.02, 7.01, 9.01); 2026-08-13 (items 5.02, 9.01); 2026-07-28 (items 2.02, 9.01); 2026-05-29 (items 1.01, 2.03, 8.01, 9.01); 2026-05-18 (items 5.07).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.